norfloxacin has been researched along with Dysentery, Bacillary in 14 studies
Norfloxacin: A synthetic fluoroquinolone (FLUOROQUINOLONES) with broad-spectrum antibacterial activity against most gram-negative and gram-positive bacteria. Norfloxacin inhibits bacterial DNA GYRASE.
norfloxacin : A quinolinemonocarboxylic acid with broad-spectrum antibacterial activity against most gram-negative and gram-positive bacteria. Norfloxacin is bactericidal and its mode of action depends on blocking of bacterial DNA replication by binding itself to an enzyme called DNA gyrase.
Dysentery, Bacillary: DYSENTERY caused by gram-negative rod-shaped enteric bacteria (ENTEROBACTERIACEAE), most often by the genus SHIGELLA. Shigella dysentery, Shigellosis, is classified into subgroups according to syndrome severity and the infectious species. Group A: SHIGELLA DYSENTERIAE (severest); Group B: SHIGELLA FLEXNERI; Group C: SHIGELLA BOYDII; and Group D: SHIGELLA SONNEI (mildest).
| Excerpt | Relevance | Reference |
|---|---|---|
| " Norfloxacin is safe and effective and showed no cartilage toxicity on short-term follow-up." | 2.68 | Double-blind, randomized clinical trial for safety and efficacy of norfloxacin for shigellosis in children. ( Bhattacharya, K; Bhattacharya, MK; Das, KP; Deb, A; Deb, M; Dutta, D; Dutta, S; Koley, H; Nair, GB, 1997) |
| "In the treatment of culture-positive shigellosis cases, the responses to therapy with both drugs were similar, except that the duration of fever, anorexia, and abdominal pain were less in those who received norfloxacin." | 2.67 | Randomized clinical trial of norfloxacin for shigellosis. ( Bhattacharya, MK; Bhattacharya, SK; Dutta, P; Moitra, A; Pal, SC; Rasaily, R; Sen, D, 1991) |
| "When 55 patients with shigellosis (26 treated with TMP-SMX, 29 treated with norfloxacin) whose bacterial isolates were susceptible to the antibiotic given were compared by treatment group, no significant differences were seen in days of illness (mean, 2." | 2.66 | Comparison of single-dose treatment with norfloxacin and standard 5-day treatment with trimethoprim-sulfamethoxazole for acute shigellosis in adults. ( Berry, SJ; Gotuzzo, E; Guzman, M; Leon-Barua, R; Maguiña, C; Oberhelman, RA; Ruiz, R; Sack, RB; Yi, A, 1989) |
| " Pharmacokinetic parameters for these dosage groups were as follows: Tmax values were 3." | 1.28 | [Pharmacokinetics and clinical studies of norfloxacin in the pediatric field]. ( Aramaki, M; Kawakami, A; Koga, T; Motohiro, T; Oda, K; Oki, S; Sasaki, H; Shimada, Y; Tsumura, N; Yoshinaga, Y, 1990) |
| "Norfloxacin is a promising drug and is more effective than nalidixic acid in the treatment of multiresistant shigellosis." | 1.27 | Comparison of norfloxacin and nalidixic acid for treatment of dysentery caused by Shigella dysenteriae type 1 in adults. ( Habiyaremye, I; Lemmens, P; Ott, D; Rogerie, F; Vandepitte, J; Verbist, L, 1986) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (28.57) | 18.7374 |
| 1990's | 10 (71.43) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bassily, S | 1 |
| Hyams, KC | 1 |
| el-Masry, NA | 1 |
| Farid, Z | 1 |
| Cross, E | 1 |
| Bourgeois, AL | 1 |
| Ayad, E | 1 |
| Hibbs, RG | 1 |
| Bhattacharya, K | 1 |
| Bhattacharya, MK | 3 |
| Dutta, D | 2 |
| Dutta, S | 1 |
| Deb, M | 1 |
| Deb, A | 1 |
| Das, KP | 1 |
| Koley, H | 1 |
| Nair, GB | 2 |
| Rataboli, PV | 1 |
| D'Souza, RS | 1 |
| Dhume, VG | 1 |
| Moolasart, P | 1 |
| Eampokalap, B | 1 |
| Ratanasrithong, M | 1 |
| Sen, D | 2 |
| Paul, M | 1 |
| Debnath, A | 1 |
| Nag, A | 1 |
| Dutta, P | 2 |
| Pal, SC | 2 |
| Bhattacharya, SK | 2 |
| Rasaily, R | 1 |
| Moitra, A | 1 |
| Zhang, YY | 1 |
| Zhun, BY | 1 |
| Jiang, SC | 2 |
| Wang, XF | 1 |
| Wei, YL | 1 |
| Motohiro, T | 1 |
| Yoshinaga, Y | 1 |
| Tsumura, N | 1 |
| Oki, S | 1 |
| Sasaki, H | 1 |
| Aramaki, M | 1 |
| Oda, K | 1 |
| Kawakami, A | 1 |
| Koga, T | 1 |
| Shimada, Y | 1 |
| Minamitani, M | 1 |
| Hachimori, K | 1 |
| Kaneda, K | 1 |
| Gotuzzo, E | 1 |
| Oberhelman, RA | 1 |
| Maguiña, C | 1 |
| Berry, SJ | 1 |
| Yi, A | 1 |
| Guzman, M | 1 |
| Ruiz, R | 1 |
| Leon-Barua, R | 1 |
| Sack, RB | 1 |
| Aoki, T | 2 |
| Shimizu, N | 2 |
| Tomizawa, I | 2 |
| Takizawa, Y | 2 |
| Matsubara, Y | 2 |
| Seo, T | 2 |
| Sagara, H | 2 |
| Tagawa, K | 2 |
| Masuda, G | 2 |
| Negishi, M | 2 |
| Rogerie, F | 1 |
| Ott, D | 1 |
| Vandepitte, J | 1 |
| Verbist, L | 1 |
| Lemmens, P | 1 |
| Habiyaremye, I | 1 |
8 trials available for norfloxacin and Dysentery, Bacillary
| Article | Year |
|---|---|
Short-course norfloxacin and trimethoprim-sulfamethoxazole treatment of shigellosis and salmonellosis in Egypt.
Topics: Adult; Aged; Developing Countries; Diarrhea; Double-Blind Method; Drug Administration Schedule; Dyse | 1994 |
Double-blind, randomized clinical trial for safety and efficacy of norfloxacin for shigellosis in children.
Topics: Anti-Infective Agents; Child, Preschool; Double-Blind Method; Dysentery, Bacillary; Female; Humans; | 1997 |
Comparison of the efficacy of ceftibuten and norfloxacin in the treatment of acute gastrointestinal infection in children.
Topics: Acute Disease; Anti-Infective Agents; Ceftibuten; Cephalosporins; Child; Child, Preschool; Diarrhea; | 1999 |
Efficacy of norfloxacin for shigellosis: a double-blind randomised clinical trial.
Topics: Adult; Double-Blind Method; Dysentery, Bacillary; Humans; Male; Nalidixic Acid; Norfloxacin; Shigell | 1992 |
Randomized clinical trial of norfloxacin for shigellosis.
Topics: Adult; Dysentery, Bacillary; Humans; Nalidixic Acid; Norfloxacin | 1991 |
[Clinical evaluation of enoxacin].
Topics: Adult; Dysentery, Bacillary; Enoxacin; Female; Gram-Negative Bacterial Infections; Humans; Male; Mid | 1991 |
Comparison of single-dose treatment with norfloxacin and standard 5-day treatment with trimethoprim-sulfamethoxazole for acute shigellosis in adults.
Topics: Adult; Clinical Trials as Topic; Diarrhea; Drug Combinations; Dysentery, Bacillary; Feces; Humans; N | 1989 |
[Comparison of clinical efficacy of norfloxacin (NFLX) and pipemidic acid (PPA) in the treatment of infectious enteritis by a double-blind method. The Japan Research Committee of Norfloxacin Research Group Enteritis].
Topics: Adolescent; Adult; Aged; Clinical Trials as Topic; Double-Blind Method; Drug Evaluation; Dysentery, | 1987 |
6 other studies available for norfloxacin and Dysentery, Bacillary
| Article | Year |
|---|---|
An unusual hallucination with norfloxacin.
Topics: Acute Disease; Adolescent; Anti-Infective Agents; Dysentery, Bacillary; Female; Hallucinations; Huma | 1996 |
[Effect of fluoroquinolones made in China in the treatment of acute bacillary dysentery. A report of 212 cases].
Topics: Acute Disease; Dysentery, Bacillary; Enoxacin; Humans; Microbial Sensitivity Tests; Norfloxacin; Shi | 1990 |
[Pharmacokinetics and clinical studies of norfloxacin in the pediatric field].
Topics: Age Factors; Child; Drug Evaluation; Drug Resistance, Microbial; Dysentery, Bacillary; Female; Human | 1990 |
[Clinical study on norfloxacin in pediatrics].
Topics: Adolescent; Age Factors; Campylobacter Infections; Child; Child, Preschool; Drug Evaluation; Dysente | 1990 |
[Clinical study of AM-715 on acute infectious enteritis. The Japan Research Committee of AM-715, Research Group for Acute Infectious Enteritis].
Topics: Acute Disease; Administration, Oral; Campylobacter Infections; Drug Administration Schedule; Dysente | 1986 |
Comparison of norfloxacin and nalidixic acid for treatment of dysentery caused by Shigella dysenteriae type 1 in adults.
Topics: Adolescent; Adult; Dysentery, Bacillary; Female; Humans; Male; Middle Aged; Nalidixic Acid; Norfloxa | 1986 |